UBS Reiterates Buy on Intel (INTC) Following 3Q15 Earnings Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. VZ

Go back to UBS Reiterates Buy on Intel (INTC) Following 3Q15 Earnings Results

FIDO Alliance Appoints American Express, Infineon, and VASCO to Board of Directors

October 14, 2015 8:00 AM EDT

MOUNTAIN VIEW, CA -- (Marketwired) -- 10/14/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today announced that American... More

FIDO Alliance Opens Worldwide Cooperation & Liaison Program - Welcomes Associations to Partner on FIDO Standards for Universal Strong Authentication

October 13, 2015 8:02 AM EDT

MOUNTAIN VIEW, CA -- (Marketwired) -- 10/13/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today introduced the FIDO Cooperation & Liaison Program, inviting associations worldwide to... More

Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms

October 12, 2015 9:38 PM EDT

JERUSALEM, ISRAEL -- (Marketwired) -- 10/12/15 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced results of the food effect study of the Phase 3 formulation of its leading product candidate, Accordion Pill Carbidopa/Levodopa, or AP-CDLD. The results demonstrated that plasma concentrations of carbidopa and levodopa were similar, with no statistically significant differences in all PK parameters... More